International Journal of Obstetric Anesthesia
Volume 19, Issue 3 , Pages 243-245 , July 2010

Oxytocin protocols during cesarean delivery: time to acknowledge the risk/benefit ratio?

,Accepted 10 May 2010.

References 

  1. Freeman RK, Nageotte M. A protocol for use of oxytocin. Am J Obstet Gynecol. 2007;197:445–446
  2. Dyer RA, van Dyk D, Dresner A. The use of uterotonic drugs during caesarean section. Int J Obstet Anesth. 2010;19:313–319
  3. Johnstone M. The cardiovascular effects of oxytocic drugs. Br J Anaesth. 1972;44:826–834
  4. D’Souza SW, Lieberman B, Cadman J, Richards B. Oxytocin induction of labour: hyponatraemia and neonatal jaundice. Eur J Obstet Gynecol Reprod Biol. 1986;22:309–317
  5. Johnson N, van Oudgaarden E, Montague I, McNamara H. The effect of oxytocin-induced hyperstimulation on fetal oxygen. BJOG. 1994;101:805–807
  6. Simpson KR, James DC. Effects of oxytocin-induced uterine hyperstimulation during labor on fetal oxygen status and fetal heart rate patterns. Am J Obstet Gynecol. 2008;199:34.e1–34.e5
  7. Beazley JM, Alderman B. Neonatal hyperbilirubinaemia following the use of oxytocin in labour. BJOG. 1975;82:265–271
  8. Schoenfeld A, Buckman G, Nissenkorn I, Cohen S, Ben-Sira I, Ovadia J. Retinal hemorrhages in the newborn following labor induced by oxytocin or dinoprostone. Arch Ophthalmol. 1985;103:932–934
  9. Why Mothers Die. The Confidential Enquiries into Maternal Deaths in the United Kingdom 1997–1999. London: RCOG Press; 2001.
  10. Thomas JS, Koh SH, Cooper GM. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section. Br J Anaesth. 2007;98:116–119
  11. Svanstrom MC, Biber B, Hanes M, Johansson G, Naslund U, Balfors EM. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section. Br J Anaesth. 2008;100:683–689
  12. Butwick AJ, Coleman L, Cohen SE, Riley ET, Carvalho B. Minimum effective bolus dose of oxytocin during elective Caesarean delivery. Br J Anaesth. 2010;104:338–343
  13. Pinder AJ, Dresner M, Calow C, Shorten GD, O’Riordan J, Johnson R. Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia. Int J Obstet Anesth. 2002;11:156–159
  14. Clark SL, Belfort MA, Dildy GA, Meyers JA. Reducing obstetric litigation through alterations in practice patterns – experience with 189 closed claims. Obstet Gynecol. 2008;112:1279–1283
  15. Formweb. FDA black box warnings. <http://www.blackboxrx.com/app/display.php?id=277/>; 2003 [accessed 5.10.10].
  16. Institute for Safe Medical Practices. High alert medications. <http://www.ismp.org/>; 2010(accessed 1.11.10.
  17. Hayes EJ, Weinstein L. Improving patient safety and uniformity of care by a standardized regimen for the use of oxytocin. Am J Obstet Gynecol. 2008;198:622.e1–622.e7
  18. Clark SL, Simpson KR, Knox GE, Garite TJ. Oxytocin: new perspectives on an old drug. Am J Obstet Gynecol. 2009;200:35.e1–35.e6
  19. Miller LA. Oxytocin, excessive uterine activity, and patient safety: time for a collaborative approach. J Perinat Neonatal Nurs. 2009;23:52–58
  20. Sarna MC, Soni AK, Gomez M, Oriol NE. Intravenous oxytocin in patients undergoing elective cesarean section. Anesth Analg. 1997;84:753–756
  21. Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC. Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2001;98:386–390
  22. Carvalho JC, Balki M, Kingdom J, Windrim R. Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstet Gynecol. 2004;104:1005–1010
  23. Balki M, Ronayne M, Davies S, et al. Minimum oxytocin dose requirement after cesarean delivery for labor arrest. Obstet Gynecol. 2006;107:45–50
  24. Robinson C, Schumann R, Zhang P, Young RC. Oxytocin-induced desensitization of the oxytocin receptor. Am J Obstet Gynecol. 2003;188:497–502
  25. Phaneuf S, Asboth G, Carrasco MP, et al. Desensitization of oxytocin receptors in human myometrium. Hum Reprod Update. 1998;4:625–633
  26. Magalhaes JK, Carvalho JC, Parkes RK, Kingdom J, Li Y, Balki M. Oxytocin pretreatment decreases oxytocin-induced myometrial contractions in pregnant rats in a concentration-dependent but not time-dependent manner. Reprod Sci. 2009;16:501–508
  27. Balki M, Cristian AL, Kingdom J, Carvalho JC. Oxytocin pretreatment of pregnant rat myometrium reduces the efficacy of oxytocin but not of ergonovine maleate or prostaglandin F 2 alpha. Reprod Sci. 2010;17:269–277
  28. Gibbs RS, Karlan BY, Haney AF, Nygaard IE. Danforth’s Obstetrics and Gynecology. 10th ed.. Philadelphia: Lippincott, Williams & Wilkins; 2008;
  29. Cunningham F, Leveno K, Bloom S, Hauth J, Rouse D, Spong C. William’s Obstetrics. 23rd ed.. New York: McGraw Hill Medical; 2009;
  30. Gabbe SG, Simpson JL, Niebyl JR. Obstetrics. fifth ed.. Philadelphia: Churchill Livingstone; 2007;

PII: S0959-289X(10)00061-0

doi: 10.1016/j.ijoa.2010.05.001

International Journal of Obstetric Anesthesia
Volume 19, Issue 3 , Pages 243-245 , July 2010

Article Tools